US Stock MarketDetailed Quotes

Axsome Therapeutics (AXSM)

Watchlist
  • 186.980
  • -2.120-1.12%
Close Jan 22 16:00 ET
  • 194.820
  • +7.840+4.19%
Pre 05:27 ET
9.43BMarket Cap-40.04P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Axsome Therapeutics (AXSM) Income Statement

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
Total revenue
63.22%170.99M
72.13%150.04M
61.95%121.46M
42.53%385.69M
66.04%118.77M
81.27%104.76M
86.65%87.17M
-20.70%75M
440.80%270.6M
193.50%71.53M
Operating revenue
63.22%170.99M
72.13%150.04M
61.95%121.46M
42.53%385.69M
66.04%118.77M
81.27%104.76M
86.65%87.17M
-20.70%75M
440.80%270.6M
193.50%71.53M
Cost of revenue
41.19%11.91M
66.95%13.45M
55.45%9.79M
27.77%33.3M
42.50%10.51M
29.16%8.44M
75.15%8.06M
-16.66%6.3M
401.44%26.07M
222.04%7.38M
Gross profit
65.15%159.08M
72.66%136.59M
62.55%111.67M
44.11%352.39M
68.74%108.25M
87.91%96.33M
87.91%79.11M
-21.05%68.7M
445.36%244.54M
190.54%64.15M
Operating expense
34.68%192M
17.04%181.41M
21.66%167.14M
41.50%604.83M
42.50%169.88M
25.53%142.56M
53.30%155M
46.85%137.39M
93.12%427.44M
53.24%119.22M
Selling and administrative expenses
57.21%150.24M
25.81%130.28M
22.04%120.79M
27.31%411.36M
30.48%113.27M
14.88%95.56M
31.19%103.55M
33.40%98.97M
102.90%323.12M
41.16%86.81M
Research and development costs
-11.51%40.16M
-0.63%49.54M
21.60%44.79M
91.00%187.08M
78.57%55.01M
57.78%45.39M
142.23%49.85M
106.99%36.83M
69.02%97.94M
109.64%30.8M
Depreciation amortization depletion
0.06%1.61M
-0.06%1.59M
-1.07%1.57M
0.27%6.39M
0.00%1.61M
-0.06%1.61M
0.06%1.59M
1.08%1.59M
54.02%6.38M
0.00%1.61M
-Depreciation and amortization
0.06%1.61M
-0.06%1.59M
-1.07%1.57M
0.27%6.39M
0.00%1.61M
-0.06%1.61M
0.06%1.59M
1.08%1.59M
54.02%6.38M
0.00%1.61M
Operating profit
28.79%-32.92M
40.94%-44.82M
19.24%-55.47M
-38.01%-252.44M
-11.92%-61.63M
25.79%-46.23M
-28.61%-75.89M
-950.90%-68.69M
-3.63%-182.91M
1.17%-55.07M
Net non-operating interest income expense
43.38%-1.12M
-41.19%-1.83M
-124.68%-2.43M
-1.80%-6.57M
-214.81%-2.21M
-161.29%-1.98M
52.42%-1.3M
52.21%-1.08M
12.02%-6.45M
46.94%-702K
Non-operating interest expense
-43.38%1.12M
41.19%1.83M
124.68%2.43M
1.80%6.57M
214.81%2.21M
161.29%1.98M
-52.42%1.3M
-52.21%1.08M
-12.02%6.45M
-46.94%702K
Other net income (expense)
19.56%-13.19M
-5.69%-2.28M
-207.08%-1.51M
42.51%-28.12M
74.58%-10.99M
-9,206.11%-16.39M
64.32%-2.16M
771.60%1.41M
-1,383.26%-48.92M
-928.74%-43.21M
Special income (charges)
19.56%-13.19M
-5.69%-2.28M
-207.08%-1.51M
42.51%-28.12M
74.58%-10.99M
-9,206.11%-16.39M
64.32%-2.16M
771.60%1.41M
-1,383.26%-48.92M
-928.74%-43.21M
-Less：Restructuring and merger&acquisition
-19.56%13.19M
-475.09%-8.1M
207.08%1.51M
-42.51%28.12M
-74.58%10.99M
9,206.11%16.39M
-64.32%2.16M
-771.60%-1.41M
1,383.26%48.92M
928.74%43.21M
-Less:Other special charges
----
--10.39M
----
----
----
----
----
----
----
----
Income before tax
26.89%-47.23M
38.33%-48.93M
13.08%-59.41M
-20.50%-287.13M
24.40%-74.83M
-2.74%-64.6M
-17.05%-79.35M
-691.35%-68.36M
-27.33%-238.28M
-61.62%-98.98M
Income tax
0
-960K
0
-91.15%85K
126.15%85K
0
0
0
960K
-325K
Net income
26.89%-47.23M
39.54%-47.97M
13.08%-59.41M
-20.05%-287.22M
24.06%-74.91M
-3.86%-64.6M
-18.13%-79.35M
-509.35%-68.36M
-27.84%-239.24M
-61.09%-98.65M
Net income continuous Operations
26.89%-47.23M
39.54%-47.97M
13.08%-59.41M
-20.05%-287.22M
24.06%-74.91M
-3.86%-64.6M
-18.13%-79.35M
-509.35%-68.36M
-27.84%-239.24M
-61.09%-98.65M
Minority interest income
Net income attributable to the parent company
26.89%-47.23M
39.54%-47.97M
13.08%-59.41M
-20.05%-287.22M
24.06%-74.91M
-3.86%-64.6M
-18.13%-79.35M
-509.35%-68.36M
-27.84%-239.24M
-61.09%-98.65M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
26.89%-47.23M
39.54%-47.97M
13.08%-59.41M
-20.05%-287.22M
24.06%-74.91M
-3.86%-64.6M
-18.13%-79.35M
-509.35%-68.36M
-27.84%-239.24M
-61.09%-98.65M
Basic earnings per share
29.85%-0.94
41.92%-0.97
15.28%-1.22
-13.66%-5.99
25.96%-1.54
-1.52%-1.34
-8.44%-1.67
-453.85%-1.44
-14.57%-5.27
-47.52%-2.08
Diluted earnings per share
29.85%-0.94
41.92%-0.97
15.28%-1.22
-13.66%-5.99
25.96%-1.54
-1.52%-1.34
-8.44%-1.67
-453.85%-1.44
-14.57%-5.27
-47.52%-2.08
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023
Total revenue 63.22%170.99M72.13%150.04M61.95%121.46M42.53%385.69M66.04%118.77M81.27%104.76M86.65%87.17M-20.70%75M440.80%270.6M193.50%71.53M
Operating revenue 63.22%170.99M72.13%150.04M61.95%121.46M42.53%385.69M66.04%118.77M81.27%104.76M86.65%87.17M-20.70%75M440.80%270.6M193.50%71.53M
Cost of revenue 41.19%11.91M66.95%13.45M55.45%9.79M27.77%33.3M42.50%10.51M29.16%8.44M75.15%8.06M-16.66%6.3M401.44%26.07M222.04%7.38M
Gross profit 65.15%159.08M72.66%136.59M62.55%111.67M44.11%352.39M68.74%108.25M87.91%96.33M87.91%79.11M-21.05%68.7M445.36%244.54M190.54%64.15M
Operating expense 34.68%192M17.04%181.41M21.66%167.14M41.50%604.83M42.50%169.88M25.53%142.56M53.30%155M46.85%137.39M93.12%427.44M53.24%119.22M
Selling and administrative expenses 57.21%150.24M25.81%130.28M22.04%120.79M27.31%411.36M30.48%113.27M14.88%95.56M31.19%103.55M33.40%98.97M102.90%323.12M41.16%86.81M
Research and development costs -11.51%40.16M-0.63%49.54M21.60%44.79M91.00%187.08M78.57%55.01M57.78%45.39M142.23%49.85M106.99%36.83M69.02%97.94M109.64%30.8M
Depreciation amortization depletion 0.06%1.61M-0.06%1.59M-1.07%1.57M0.27%6.39M0.00%1.61M-0.06%1.61M0.06%1.59M1.08%1.59M54.02%6.38M0.00%1.61M
-Depreciation and amortization 0.06%1.61M-0.06%1.59M-1.07%1.57M0.27%6.39M0.00%1.61M-0.06%1.61M0.06%1.59M1.08%1.59M54.02%6.38M0.00%1.61M
Operating profit 28.79%-32.92M40.94%-44.82M19.24%-55.47M-38.01%-252.44M-11.92%-61.63M25.79%-46.23M-28.61%-75.89M-950.90%-68.69M-3.63%-182.91M1.17%-55.07M
Net non-operating interest income expense 43.38%-1.12M-41.19%-1.83M-124.68%-2.43M-1.80%-6.57M-214.81%-2.21M-161.29%-1.98M52.42%-1.3M52.21%-1.08M12.02%-6.45M46.94%-702K
Non-operating interest expense -43.38%1.12M41.19%1.83M124.68%2.43M1.80%6.57M214.81%2.21M161.29%1.98M-52.42%1.3M-52.21%1.08M-12.02%6.45M-46.94%702K
Other net income (expense) 19.56%-13.19M-5.69%-2.28M-207.08%-1.51M42.51%-28.12M74.58%-10.99M-9,206.11%-16.39M64.32%-2.16M771.60%1.41M-1,383.26%-48.92M-928.74%-43.21M
Special income (charges) 19.56%-13.19M-5.69%-2.28M-207.08%-1.51M42.51%-28.12M74.58%-10.99M-9,206.11%-16.39M64.32%-2.16M771.60%1.41M-1,383.26%-48.92M-928.74%-43.21M
-Less：Restructuring and merger&acquisition -19.56%13.19M-475.09%-8.1M207.08%1.51M-42.51%28.12M-74.58%10.99M9,206.11%16.39M-64.32%2.16M-771.60%-1.41M1,383.26%48.92M928.74%43.21M
-Less:Other special charges ------10.39M--------------------------------
Income before tax 26.89%-47.23M38.33%-48.93M13.08%-59.41M-20.50%-287.13M24.40%-74.83M-2.74%-64.6M-17.05%-79.35M-691.35%-68.36M-27.33%-238.28M-61.62%-98.98M
Income tax 0-960K0-91.15%85K126.15%85K000960K-325K
Net income 26.89%-47.23M39.54%-47.97M13.08%-59.41M-20.05%-287.22M24.06%-74.91M-3.86%-64.6M-18.13%-79.35M-509.35%-68.36M-27.84%-239.24M-61.09%-98.65M
Net income continuous Operations 26.89%-47.23M39.54%-47.97M13.08%-59.41M-20.05%-287.22M24.06%-74.91M-3.86%-64.6M-18.13%-79.35M-509.35%-68.36M-27.84%-239.24M-61.09%-98.65M
Minority interest income
Net income attributable to the parent company 26.89%-47.23M39.54%-47.97M13.08%-59.41M-20.05%-287.22M24.06%-74.91M-3.86%-64.6M-18.13%-79.35M-509.35%-68.36M-27.84%-239.24M-61.09%-98.65M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders 26.89%-47.23M39.54%-47.97M13.08%-59.41M-20.05%-287.22M24.06%-74.91M-3.86%-64.6M-18.13%-79.35M-509.35%-68.36M-27.84%-239.24M-61.09%-98.65M
Basic earnings per share 29.85%-0.9441.92%-0.9715.28%-1.22-13.66%-5.9925.96%-1.54-1.52%-1.34-8.44%-1.67-453.85%-1.44-14.57%-5.27-47.52%-2.08
Diluted earnings per share 29.85%-0.9441.92%-0.9715.28%-1.22-13.66%-5.9925.96%-1.54-1.52%-1.34-8.44%-1.67-453.85%-1.44-14.57%-5.27-47.52%-2.08
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion--------Unqualified Opinion--
Market Insights
Nancy Pelosi Portfolio
No. Symbol % Chg
Sample Name
Sample Code
 +4.65%
Sample Name
Sample Code
 +4.15%
Sample Name
Sample Code
 +2.94%
4
Clean Energy Fuels
CLNE
+2.70%
5
American Express
AXP
+2.34%
China Concept Stocks
No. Symbol 5D % Chg
Sample Name
Sample Code
 +24.00%
Sample Name
Sample Code
 +7.99%
Sample Name
Sample Code
 +7.44%
4
KE Holdings
BEKE
+5.08%
5
NIO Inc
NIO
+4.61%
View More
The Fed Delivers Third Consecutive Rate Cut as Expected! How to Position for Year-End U.S. Equity Ma
On December 19, the Bank of Japan raised interest rates by 25 basis points as expected, in line with market forecasts. On the evening of Dec Show More
December FOMC Interest Rate Meeting
[Opportunity Express] MRVL Continues to Bet on Optical Interconnects: Is Now a Good Time to Enter the Market?

- No more -